Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 3/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6739600 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6743638 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6739120 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6741614 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6743010 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6740677 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6741344 | 0.99 | S1PR3 (0.48) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL6738870 | 0.96 | WDR5 (0.52) | WDR5S1PR3THRATHRBESR1 | |
| SCHEMBL5845456 | 0.90 | S1PR3 (0.48) | WDR5S1PR3THRATHRBHTT | |
| SCHEMBL5843745 | 0.88 | S1PR3 (0.50) | S1PR3THRATHRBHTTS1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689530-B2 | ULTRAVIOLET LITHOGRAPHY MICROFABRICATION WITH IMPROVED RESOLUTION AND PATTERN PROFILE AFTER DEVELOPMENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-20030180653-A1 | Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180653-A1 | Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process | CACNA1A, KCNA1, POLL | WDR5 3957/4885S1PR3 3916/4885THRA 4108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.